MedPath

Comparison of Telmisartan a blood pressure lowering agent with other blood pressure lowering agents on its effects on insulin sensitivity, inflammation and vascular function in patients of type 2 diabetes with high blood pressure : an open label interventional study

Phase 3
Conditions
Health Condition 1: I10- Essential (primary) hypertensionHealth Condition 2: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/04/051878
Lead Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES Jodhpur Rajasthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

18-75 years of age SBP >140 mmHg DBP >90mmHg Diagnosed case of T2DM HbA1c between 7% and 10% Patients on metformin and /or DPP4 inhibitors

Exclusion Criteria

Pregnancy lactation T1DM Patients with heart failure ischemic stroke hemorrhagic stroke Traumatic brain injury malignancy patients on steroids immunosuppressants over a long time patients on exogenous insulin patients on mental and immune system disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of telmisartan with other anti hypertensives on insulin resistance in terms of HOMA IR valuesTimepoint: Baseline and after three months
Secondary Outcome Measures
NameTimeMethod
compare the effect of telmisartan with other anti-hypertensives on the levels of inflammatory marker CRPTimepoint: Baseline and after 3 months;To compare the effect of telmisartan with other anti-hypertensives on the levels of inflammatory markers IL 6Timepoint: Baseline and after 3 months;To compare the effect of telmisartan with other anti-hypertensives on the levels of inflammatory markers TNF alphaTimepoint: Baseline and after 3 months;To compare the effect of telmisartan with other anti-hypertensives on the levels of vascular endothelin 1Timepoint: Baseline and after 3 months
© Copyright 2025. All Rights Reserved by MedPath